Get started
Author

Luis Alberto Chi‐Cervera

Observed names: L. Chi-Cervera, L.A. Cervera, L.A. Chi-Cervera, Luis A. Cervera, Luis A. Chi Cervera, Luis A. Chi-Cervera, Luis A. Chi‐Cervera, Luis Alberto Chi-Cervera, Luis Chi-Cervera
Observed institutions: Universidad Complutense de Madrid, Hospital Universitario Virgen Macarena, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Hospital Universitario de Burgos, Hospital El Bierzo, Universitätsklinikum Aachen, Hospital Universitario Virgen del Rocío, Hospital Clínico Universitario de Valladolid, Hospital Universitario Río Hortega, Complejo Asistencial Universitario de Palencia, Hospital Christus Muguerza Alta Especialidad, Complejo Asistencial Universitario de León, University of Arkansas for Medical Sciences, RWTH Aachen University
ORCID: 0000-0002-3335-8178
Observed ORCID: 0000-0002-3335-8178
OpenAlex ID: A5021247344
Sodium‐Glucose Cotransporter 2 Inhibitors Ameliorate Ascites and Peripheral Edema in Patients With Cirrhosis and Diabetes
2020 · Iaarah Montalvo‐Gordon, Luis Alberto Chi‐Cervera, et al. · Hepatology · 69
Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis
2016 · Astrid Ruiz-Margáin, Ricardo Ulises Macías-Rodríguez, et al. · World Journal of Gastroenterology · 50
PDF
Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
2023 · Alberto Queiroz Farias, Anna Curto Vilalta, et al. · Gastroenterology · 49
PDF
Fibroblast growth factor 21 is an early predictor of acute‐on‐chronic liver failure in critically ill patients with cirrhosis
2018 · Astrid Ruiz‐Margáin, Alessandra Pohlmann, et al. · Liver Transplantation · 37
PDF
Optimizing nutrition in hepatic cirrhosis: A comprehensive assessment and care approach
2024 · Osvely Mendez-Guerrero, Anaisa Carranza-Carrasco, et al. · World Journal of Gastroenterology · 27
Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study
2022 · R. Bernal-Reyes, M.E. Icaza-Chávez, et al. · Revista de Gastroenterología de México (English Edition) · 25
PDF
Is the Sars‐CoV‐2 virus a possible trigger agent for the development of achalasia?
2022 · Janette Furuzawa-Carballeda, María Eugenia Icaza-Chávez, et al. · Neurogastroenterology & Motility · 24
PDF
Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®)
2020 · Luis Chi-Cervera, Gordon Montalvo, et al. · Journal of Medical Biochemistry · 14
PDF
Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy
2015 · Federico Sáez-Royuela, Pedro Linares, et al. · European Journal of Gastroenterology & Hepatology · 11
Prevalencia y características clínico-epidemiológicas de una población mexicana con enfermedad del hígado graso asociada a disfunción metabólica: un estudio en población abierta
2022 · R. Bernal-Reyes, M.E. Icaza-Chávez, et al. · Revista de Gastroenterología de México · 9
PDF
Increased incidence of and microbiologic changes in pyogenic liver abscesses in the Mexican population
2020 · Juanita Pérez-Escobar, Wagner Ramirez-Quesada, et al. · World Journal of Hepatology · 8
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
2022 · Giovanni Alejandro Salgado Alvarez, Samanta Mayanin Pinto Galvez, et al. · World Journal of Hepatology · 6
Análisis de la composición corporal y ángulo de fase por bioimpedancia en pacientes con MAFLD
2021 · Samanta Mayanin Pinto Gálvez, Uriel García-Mora, et al. · Gastroenterología y Hepatología · 4
Body composition and phase angle by bioimpedance in patients with MAFLD
2022 · Samanta Mayanin Pinto Gálvez, Uriel García-Mora, et al. · Gastroenterología y Hepatología (English Edition) · 2
Su376 METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN GENERAL POPULATION IN MEXICO: PREVALENCE, CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS.
2021 · Luis A. Chi Cervera, Jose Maria Remes-Troche, et al. · Gastroenterology · 2
Phase Angle as an Early Nutritional Marker of Short-Term Outcome in Hospitalized Patients with Cirrhosis
2016 · A. Ruiz-Margáin, R. Macias-Rodriguez, et al. · Journal of Hepatology · 2
Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023
2024 · Linda E. Munoz-Espinosa, Aldo Torre, et al. · Annals of Hepatology · 1
P0720 : Improvement of advanced liver fibrosis and regression of liver cirrhosis in patients with hepatitis C genotype 1 after HCV protease inhibitor-based triple therapy
2015 · F. Sáez-Royuela, P. Linares, et al. · Journal of Hepatology · 1
Índice metabólico como marcador predictivo no invasivo de esteatosis hepática en pacientes con enfermedad del hígado graso no alcohólico
2026 · Julio Lara-Riegos, Luis Alberto Chi-Cervera, et al. · Medicina Clínica
Metabolic index a non-invasive predictive marker of liver steatosis in patients with non-alcoholic fatty liver disease
2026 · Julio Lara-Riegos, Luis Alberto Chi-Cervera, et al. · Medicina Clínica (English Edition)
434 Is the Sars-cov-2 Virus a Trigger Agent for the Development of Achalasia?
2023 · Gonzalo Torres-Villalobos, Janette Furuzawa-Carballeda, et al. · Gastroenterology
PDF
Su378 ASSOCIATION OF THE METABOLIC STATUS WITH THE PRESENCE OF ADVANCED LIVER FIBROSIS IN MEXICAN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE (MAFLD)
2021 · Osvely Méndez-Guerrero, Luis A. Chi Cervera, et al. · Gastroenterology
Sa344 BODY ADIPOSITY MAY CONTRIBUTE TO METABOLIC ASSOCIATED FATTY LIVER DISEASE
2021 · Sophia E. Martinez Vazquez, Mercedes Amieva-Balmori, et al. · Gastroenterology
Works count: 23
Citation count: 341
H-index: 9
I10-index: 9
Year
Topic
Type